Clinical trials
Terminated Observational Lymphoma, Follicular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt-Ingram Cancer Center | 3 |
| Boston University | 1 |
| Celgene | 1 |
| City of Hope Medical Center | 1 |
| Columbia University | 1 |
| Danone Nutricia Research | 1 |
| Hoffmann-La Roche | 1 |
| Juno Therapeutics, a Subsidiary of Celgene | 1 |
| Nantes University Hospital | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 17 |
| Lymphoma, Non-Hodgkin | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Mantle-Cell | 10 |
| Burkitt Lymphoma | 9 |
| Congenital Abnormalities | 9 |
| Hodgkin Disease | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Lymphoma, B-Cell, Marginal Zone | 9 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.